The Library
Commentary : controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease
Tools
Tools
Tools
Cappuccio, Francesco P.. (2008) Commentary : controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease. BMJ, Vol.336 . pp. 1248-1249. ISSN 0959-535X
![[img]](http://wrap.warwick.ac.uk/style/images/fileicons/application_pdf.png)
|
PDF
WRAP_Cappuccio_0482983-061008-BMJ_2008_NICE_lipids.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Download (249Kb) |
Official URL: http://dx.doi.org/10.1136/bmj.39580.424352.AD
Abstract
The new guidelines from the National Institute for Health and Clinical Excellence (NICE) on lipid modification for the prevention of cardiovascular disease will guide the way we assess cardiovascular risk and treat lipids, both in primary and in secondary care. What are the new aspects, and what is it that might spark controversy in this new publication?
| Item Type: | Journal Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Divisions: | Faculty of Medicine > Warwick Medical School > Clinical Sciences Research Institute (CSRI) Faculty of Medicine > Warwick Medical School |
| Library of Congress Subject Headings (LCSH): | National Institute for Clinical Excellence (Great Britain), Cardiovascular system -- Diseases |
| Journal or Publication Title: | BMJ |
| Publisher: | BMJ Publishing Group Ltd. |
| ISSN: | 0959-535X |
| Date: | 31 May 2008 |
| Volume: | Vol.336 |
| Page Range: | pp. 1248-1249 |
| Identification Number: | 10.1136/bmj.39580.424352.AD |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Open Access |
| References: | 1 Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM. Application of Framingham risk estimates to ethnic minorities in the UK and implications for primary prevention in general practice: a cross sectional population based study. BMJ 2002;325:1271-4. 2 BrindleP,MayM,GillP,CappuccioFP,D’AgostinoRSr, FischbacherC, et al. Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups. Heart 2006;92:1595-602. 3 LittleP,Kelly J,Barnett J,DorwardM,MargettsB,WarmD.Randomised controlled factorial trialofdietaryadvicefor patientswithasinglehigh blood pressure reading in primary care. BMJ 2004;328:1054-7. 4 World Health Organization. Reducing salt intake in populations: report of a WHO forum and technical meeting. Geneva: WHO, 2007:1-60. 5 Cappuccio FP. Salt and cardiovascular disease. BMJ 2007;334:859-60. 6 Sever PS,Dahlöf B, Poulter NR,Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. Lancet 2003;361:1149-58. 7 British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association. JBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(suppl 5):v1-52. 8 WilliamsB, PoulterNR,BrownMJ, DavisM,McInnes GT,Potter JF, et al. Guidelines for management of hypertension: report of the fourth working party of theBritish HypertensionSociety, 2004-BHSIV.JHum Hypertens 2004;18:139-85. |
| URI: | http://wrap.warwick.ac.uk/id/eprint/172 |
Data sourced from Thomson Reuters' Web of Knowledge
Actions (login required)
 |
View Item |
